+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lyophilization Services Market for Biopharmaceuticals by Type of Biologic Lyophilized, Type of Primary Packaging System and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • PDF Icon

    Report

  • 225 Pages
  • April 2022
  • Region: Global
  • Roots Analysis
  • ID: 5578615
Description Jump to:
Over the last decade, a steady rise has been observed in the annual number of approvals for various types of biologics (including monoclonal antibodies, cell therapies, recombinant proteins, vaccines and gene therapies). In addition, more than 8,000 biological therapeutics are currently being evaluated in clinical trials, being conducted across the globe. Evidently, biologics have emerged as one of the fastest growing segments in the pharmaceutical industry. Driven by several advantages offered by biologics over small molecules (including high efficacy, target specificity and favorable safety profiles), the biopharmaceutical market is anticipated to witness continued and consistent growth over the next several years. However, there are a variety of challenges associated with such therapies. For instance, biological drugs are inherently less stable as compared to small molecules and, therefore, more prone to physical and chemical degradation. In order to achieve longer and commercially viable shelf lives, players are actively adopting the lyophilization (also known as freeze-drying) technique; it enables the production of stable dry biopharmaceutical formulations. In this context, it is worth highlighting that around 50% of the currently approved biopharmaceuticals are injectables. Of these, about one third of the drug candidates are being lyophilized.

Setting up in-house lyophilization capabilities and operations is an expensive and time-consuming process, which requires specialized lyophilization equipment and expertise. Considering the high capital investment and technical / routine operations-related challenges associated with lyophilization of biopharmaceuticals, a growing number of biologic developers are outsourcing their lyophilization operations to qualified contract manufacturing organizations (CMOs) in order to leverage their capabilities and yield cost savings opportunities. Presently, more than 105 contract manufacturers claim to have the required capabilities to offer lyophilization services for biotherapeutics. In addition, lyophilization service providers are entering into strategic alliances in order to consolidate their presence in this field and enhance existing capabilities to meet the growing demand for biologics. Driven by the increasing preference for outsourcing, continuous growth of the biological therapeutics pipeline and a steady rise in drug approvals, the lyophilization services market for biopharmaceuticals is likely to witness steady growth in the foreseen future.


Scope of the Report


The “Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized (Antibodies, Cell and Gene Therapies, Vaccines and Other Biologics), Type of Primary Packaging System (Vials, Syringes, Cartridges, Ampoules and Others) and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) - Industry Trends and Global Forecasts, 2022-2035” report features an extensive study of companies engaged in offering lyophilization services for biopharmaceuticals. The study features an in-depth analysis of the key drivers and trends related to this domain. 


Amongst other elements, the report includes:

  • A detailed assessment of the current landscape of companies offering lyophilization services for biopharmaceuticals, along with information on their year of establishment, company size (in terms of employee count), location of headquarters, scale of operation (preclinical, clinical and commercial), regulatory certification / accreditation, type of biologic lyophilized (proteins, antibodies, vaccines, nucleic acids, cell / gene therapies, others and biologics (unspecified)), process of lyophilization (bulk lyophilization and individual lyophilization), type of primary packaging system (vials, pre-filled syringes, cartridges, ampoules and others) and additional services offered by the firms (lyophilization cycle development and lyophilization cycle optimization).
  • An insightful benchmark analysis of various service providers segregated into three peer groups based on location of their headquarters (North America, Europe, and Asia Pacific and RoW). The companies were further distributed across key geographies, based on their employee count, into three categories, namely small (1-200 employees), mid-sized (201-500 employees) and large / very large (>500 employees), highlighting the top players in this domain, based on their respective capabilities.
  • Elaborate profiles of prominent players offering lyophilization services for biopharmaceuticals, based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to lyophilization service offerings for biopharmaceuticals, dedicated facilities, recent developments and an informed future outlook.
  • An analysis of the partnerships that have been inked by stakeholders engaged in this domain, covering acquisitions, asset acquisitions, product / technology development agreements, and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, most active players (in terms of number of partnerships) and regional distribution of the collaborations.
  • A detailed analysis of the recent expansions undertaken by various lyophilization service providers for biopharmaceuticals, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansions, facility expansions and new facility addition), company size (small, mid-sized, large and very large companies), location of headquarters, location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution.
  • A survey analysis presenting additional insights on lyophilization services offered for biopharmaceuticals, apart from those mentioned on the service provider’s website. Inputs for this chapter were gathered across key parameters, including type of biologic lyophilized, type of primary packaging system, scale of operation, availability of lyophilization cycle development / optimization capabilities and location of dedicated manufacturing facility for lyophilization. Additionally, through the questionnaire we obtained some insights on the likely size of the current market for lyophilization services for biopharmaceuticals.
  • A case study on lyophilization cycle development and optimization services, highlighting the important parameters and techniques required for these processes. Further, the chapter presents the list of players that provide such services for biopharmaceuticals.
  • A case study on alternative approaches to the lyophilization process, such as spray drying, spray freeze drying, atmospheric spray freeze drying and vacuum foam drying.
  • One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for lyophilization services market for biopharmaceuticals over the coming decade. We have provided an informed estimate on the likely evolution of the market over the period 2022-2035. The report features a detailed forecast of the overall lyophilization services market for biopharmaceuticals, wherein both the current and upcoming opportunity is segmented across [A] type of biologic lyophilized (antibodies, cell and gene therapies, vaccines and other biologics), [B] type of primary packaging system (vials, syringes, cartridges, ampoules and others) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). In order to account for future uncertainties and add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.


The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals:

  • Brian Sasaki (Director of Business Development) and Thomas Ingallinera (Vice President of Technical Support), Pharmaceutical International
  • Doreen Coull (Regional Sales Director, Curia)
  • Patrick DePalma (Former Director of CMO Business Development, BioDefense Division, Emergent BioSolutions)
  • Rocio Gonzalez Rodriguez (Head of CDMO Project Management, Liof Pharma)
  • John Shaw (Former Head of Business Development and Marketing, Vibalogics)
  • Sophia Kim (Commercial DP (Depository Participant) Sales / Group Leader, Samsung Biologics)
  • Marianna Tcherpakov (Business Development Manager, Bioserv)
  • Adam Inche (Marketing Manager, Symbiosis Pharmaceutical Services)
  • Adam Viverette (Lyophilization Manager, Patheon)
  • Steven Nail (Principal Scientist, Baxter BioPharma Solutions)


Key Questions Answered

  • Who are the key players engaged in offering lyophilization services for biopharmaceuticals?
  • What is the relative competitiveness of lyophilization service providers for biopharmaceuticals?
  • What type of partnership models are commonly adopted by stakeholders in this industry?
  • What are the different types of expansion initiatives being undertaken by lyophilization service providers for biopharmaceuticals?
  • What are the key market trends and driving factors that are likely to impact this market?
  • How is the current and future market opportunity likely to be distributed across key segments?

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Lyophilization
3.2.1. Historical Evolution
3.2.2. Underlying Principles
3.2.3. Advantages and Disadvantages
3.3. Lyophilization of Biopharmaceuticals
3.3.1. Need for Lyophilization of Biopharmaceuticals
3.3.2. Lyophilization Process
3.3.2.1. Formulation and Filling
3.3.2.2. Freezing
3.3.2.3. Primary Drying
3.3.2.4. Secondary Drying
3.4. Lyophilizer and its Key Components
3.5. Primary Packaging Systems Used for Lyophilization of Biopharmaceuticals
3.6. Lyophilization Cycle Development and Optimization
3.7. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Lyophilization Service Providers for Biopharmaceuticals: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Scale of Operation
4.2.5. Analysis by Regulatory Certification / Accreditation
4.2.6. Analysis by Type of Biologic Lyophilized
4.2.7. Analysis by Process of Lyophilization
4.2.8. Analysis by Type of Primary Packaging System
4.2.9. Analysis by Additional Services Offered
5. BENCHMARK ANALYSIS
5.1. Chapter Overview
5.2. Methodology
5.3. Benchmark Analysis: Peer Groups
5.3.1. Benchmark Analysis: North America (Peer Group I)
5.3.2. Benchmark Analysis: North America (Peer Group II)
5.3.3. Benchmark Analysis: North America (Peer Group III)
5.3.4. Benchmark Analysis: Europe (Peer Group IV)
5.3.5. Benchmark Analysis: Europe (Peer Group V)
5.3.6. Benchmark Analysis: Europe (Peer Group VI)
5.3.7. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
5.3.8. Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)
6. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Baxter BioPharma Solutions
6.2.1. Company Overview
6.2.2. Lyophilization Service Offerings for Biopharmaceuticals
6.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.2.4. Recent Developments and Future Outlook
6.3. Curia
6.3.1. Company Overview
6.3.2. Lyophilization Service Offerings for Biopharmaceuticals
6.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.3.4. Recent Developments and Future Outlook
6.4. Emergent BioSolutions
6.4.1. Company Overview
6.4.2. Lyophilization Service Offerings for Biopharmaceuticals
6.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.4.4. Recent Developments and Future Outlook
6.5. LSNE Contract Manufacturing
6.5.1. Company Overview
6.5.2. Lyophilization Service Offerings for Biopharmaceuticals
6.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.5.4. Recent Developments and Future Outlook
6.6. Lyophilization Technology
6.6.1. Company Overview
6.6.2. Lyophilization Service Offerings for Biopharmaceuticals
6.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
6.6.4. Recent Developments and Future Outlook
7. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN EUROPE
7.1. Chapter Overview
7.2. CordenPharma
7.2.1. Company Overview
7.2.2. Lyophilization Service Offerings for Biopharmaceuticals
7.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.2.4. Recent Developments and Future Outlook
7.3. Coriolis Pharma
7.3.1. Company Overview
7.3.2. Lyophilization Service Offerings for Biopharmaceuticals
7.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.3.4. Recent Developments and Future Outlook
7.4. Northway Biotech
7.4.1. Company Overview
7.4.2. Lyophilization Service Offerings for Biopharmaceuticals
7.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.4.4. Recent Developments and Future Outlook
7.5. ProJect Pharmaceutics
7.5.1. Company Overview
7.5.2. Lyophilization Service Offerings for Biopharmaceuticals
7.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.5.4. Recent Developments and Future Outlook
7.6. Vetter Pharma
7.6.1. Company Overview
7.6.2. Lyophilization Service Offerings for Biopharmaceuticals
7.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
7.6.4. Recent Developments and Future Outlook
8. COMPANY PROFILES: LYOPHILIZATION SERVICE PROVIDERS FOR BIOPHARMACEUTICALS IN ASIA PACIFIC
8.1. Chapter Overview
8.2. BioZed Engineering
8.2.1. Company Overview
8.2.2. Lyophilization Service Offerings for Biopharmaceuticals
8.2.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.2.4. Recent Developments and Future Outlook
8.3. CinnaGen
8.3.1. Company Overview
8.3.2. Lyophilization Service Offerings for Biopharmaceuticals
8.3.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.3.4. Recent Developments and Future Outlook
8.4. MabPlex
8.4.1. Company Overview
8.4.2. Lyophilization Service Offerings for Biopharmaceuticals
8.4.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.4.4. Recent Developments and Future Outlook
8.5. Samsung Biologics
8.5.1. Company Overview
8.5.2. Lyophilization Service Offerings for Biopharmaceuticals
8.5.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.5.4. Recent Developments and Future Outlook
8.6. WuXi Biologics
8.6.1. Company Overview
8.6.2. Lyophilization Service Offerings for Biopharmaceuticals
8.6.3. Dedicated Biopharmaceutical Lyophilization Facilities
8.6.4. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Most Active Players: Analysis by Number of Partnerships
9.3.5. Analysis by Geography
9.3.5.1. Intercontinental and Intracontinental Deals
9.3.5.2. International and Local Deals
10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Lyophilization Services Market for Biopharmaceuticals: List of Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Year and Type of Expansion
10.2.4. Analysis by Company Size and Location of Headquarters
10.2.5. Analysis by Location of Expanded Facility
10.2.6. Active Players: Analysis by Number of Recent Expansions
10.2.7. Analysis by Geography
11. SURVEY ANALYSIS
11.1. Chapter Overview
11.2. Lyophilization Services Market for Biopharmaceuticals: List of Participating Companies
11.2.1. Analysis by Seniority Level of Respondents
11.2.2 Analysis by Type of Biologic Lyophilized
11.2.3. Analysis by Type of Primary Packaging System
11.2.4. Analysis by Scale of Operation
11.2.5. Analysis by Additional Services Offered
11.2.6. Analysis by Location of Lyophilization Facility
11.2.7. Analysis by Share of Lyophilization Operations Outsourced
11.2.8. Analysis by Likely Market Size
11.2.9. Analysis of Likely Market Share by Type of Biologic Lyophilized
11.2.10. Analysis of Likely Market Share by Geography
12. CASE STUDY I: LYOPHILIZATION CYCLE DEVELOPMENT AND OPTIMIZATION
12.1. Chapter Overview
12.2. Lyophilization Cycle Development
12.3. Lyophilization Cycle Optimization
12.4. Lyophilization Cycle Development and Optimization: List of Service Providers
12.4.1. Analysis by Company Size
12.4.2. Analysis by Location of Headquarters
12.4.3. Analysis by Type of Service Offered
12.4.4 Lyophilization Cycle Development and Optimization Service Providers: Company Snapshots
13. CASE STUDY II: ALTERNATIVE APPROACHES TO LYOPHILIZATION
13.1. Chapter Overview
13.2. Alternative Approaches to Lyophilization
13.2.1. Spray Drying
13.2.1.1. Spray Drying Process
13.2.1.2. Applications of Spray Drying
13.2.1.3. Spray Drying of Biopharmaceuticals
13.2.1.4. Spray Drying Service Providers for Biopharmaceuticals
13.2.1.5. Comparison of Lyophilization and Spray Drying
13.2.2. Spray Freeze Drying
13.2.3. Atmospheric Spray Freeze Drying
13.2.4. Vacuum Foam Drying
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Global Lyophilization Services Market for Biopharmaceuticals, 2022-2035
14.4. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, 2022 and 2035
14.4.1. Lyophilization Services Market for Antibodies, 2022-2035
14.4.2. Lyophilization Services Market for Cell and Gene Therapies, 2022-2035
14.4.3. Lyophilization Services Market for Vaccines, 2022-2035
14.4.4. Lyophilization Services Market for Other Biologics, 2022-2035
14.5. Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, 2022 and 2035
14.5.1. Lyophilization Services Market for Biopharmaceuticals for Vials, 2022-2035
14.5.2. Lyophilization Services Market for Biopharmaceuticals for Syringes, 2022-2035
14.5.3. Lyophilization Services Market for Biopharmaceuticals for Cartridges, 2022-2035
14.5.4. Lyophilization Services Market for Biopharmaceuticals for Ampoules, 2022-2035
14.5.5. Lyophilization Services Market for Biopharmaceuticals for Other Primary Packaging Systems, 2022-2035
14.6. Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, 2022 and 2035
14.6.1. Lyophilization Services Market for Biopharmaceuticals in North America, 2022-2035
14.6.2. Lyophilization Services Market for Biopharmaceuticals in Europe, 2022-2035
14.6.3. Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, 2022-2035
14.6.4. Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, 2022-2035
14.6.5. Lyophilization Services Market for Biopharmaceuticals in Latin America, 2022-2035
14.6.6. Lyophilization Services Market for Biopharmaceuticals in Rest of the World, 2022-2035
15. CONCLUDING REMARKS
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Pharmaceutical International
16.2.1. Company Snapshot
16.2.2. Interview Transcript: Brian Sasaki, Director of Business Development and Thomas Ingallinera, Vice President of Technical Support
16.3. Curia
16.3.1. Company Snapshot
16.3.2. Interview Transcript: Doreen Coull, Regional Sales Director
16.4. Emergent BioSolutions
16.4.1. Company Snapshot
16.4.2. Interview Transcript: Patrick DePalma, Former Director, CMO Business Development, BioDefense Division
16.5. Liof Pharma
16.5.1. Company Snapshot
16.5.2. Interview Transcript: Rocio Gonzalez Rodriguez, Head of CDMO Project Management
16.6. Vibalogics
16.6.1. Company Snapshot
16.6.2. Interview Transcript: John Shaw, Former Head of Business Development and Marketing
16.7. Samsung Biologics
16.7.1. Company Snapshot
16.7.2. Interview Transcript: Sophia Kim, Commercial DP (Depository Participant) Sales / Group Leader
16.8. Bioserv
16.8.1. Company Snapshot
16.8.2. Interview Transcript: Marianna Tcherpakov, Business Development Manager
16.9. Symbiosis Pharmaceutical Services
16.9.1. Company Snapshot
16.9.2. Interview Transcript: Adam Inche, Marketing Manager
16.10. Patheon
16.10.1. Company Snapshot
16.10.2. Interview Transcript: Adam Viverette, Manager of Lyophilization Operations
16.11. Baxter BioPharma Solutions
16.11.1. Company Snapshot
16.11.2. Interview Transcript: Steven Nail, Principal Scientist
17. APPENDIX 1: TABULATED DATA18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION
List Of Figures
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Recent Expansions
Figure 2.4 Executive Summary: Survey Analysis
Figure 2.5 Executive Summary: Market Forecast
Figure 3.1 Historical Evolution of Lyophilization
Figure 3.2 Phase Diagram of Water
Figure 3.3 Sublimation of Ice Crystals
Figure 3.4 Key Steps Involved in Formulation and Filling of Biopharmaceuticals
Figure 3.5 Key Components of Lyophilizer
Figure 4.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
Figure 4.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
Figure 4.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
Figure 4.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
Figure 4.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
Figure 4.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
Figure 4.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
Figure 4.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
Figure 4.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
Figure 5.1 Benchmark Analysis: Distribution by Company Size
Figure 5.2 Benchmark Analysis: North America (Peer Group I)
Figure 5.3 Benchmark Analysis: North America (Peer Group II)
Figure 5.4 Benchmark Analysis: North America (Peer Group III)
Figure 5.5 Benchmark Analysis: Europe (Peer Group IV)
Figure 5.6 Benchmark Analysis: Europe (Peer Group V)
Figure 5.7 Benchmark Analysis: Europe (Peer Group VI)
Figure 5.8 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VII)
Figure 5.9 Benchmark Analysis: Asia Pacific and Rest of the World (Peer Group VIII)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Most Active Players: Distribution by Number of Partnerships
Figure 9.5 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Figure 9.6 Partnerships and Collaborations: International and Local Deals
Figure 10.1 Recent Expansions: Cumulative Year-wise Trend, 2018-2021
Figure 10.2 Recent Expansions: Distribution by Type of Expansion
Figure 10.3 Recent Expansions: Distribution by Year and Type of Expansion
Figure 10.4 Recent Expansions: Distribution by Company Size and Location of Headquarters
Figure 10.5 Recent Expansions: Distribution by Location of Expanded Facility
Figure 10.6 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
Figure 10.7 Active Players: Distribution by Number of Recent Expansions
Figure 10.8 Recent Expansions: Distribution by Geography
Figure 11.1 Survey Analysis: Distribution by Geographical Location of Respondents
Figure 11.2 Survey Analysis: Distribution by Seniority Levels of Respondents
Figure 11.3 Survey Analysis: Distribution by Type of Biologic Lyophilized
Figure 11.4 Survey Analysis: Distribution by Type of Primary Packaging System
Figure 11.5 Survey Analysis: Distribution by Scale of Operation
Figure 11.6 Survey Analysis: Distribution by Additional Services Offered
Figure 11.7 Survey Analysis: Distribution by Location of Lyophilization Facility
Figure 11.8 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
Figure 11.9 Survey Analysis: Distribution by Likely Current Market Size
Figure 11.10 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
Figure 11.11 Survey Analysis: Distribution of Likely Market Share by Geography
Figure 12.1 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
Figure 12.2 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
Figure 12.3 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
Figure 13.1 Key Steps Involved in Spray Drying Process
Figure 14.1 Global Lyophilization Services Market for Biopharmaceuticals, 2022-2035 (USD Billion)
Figure 14.2 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, 2022 and 2035 (USD Billion)
Figure 14.3 Lyophilization Services Market for Antibodies, 2022-2035 (USD Billion)
Figure 14.4 Lyophilization Services Market for Cell and Gene Therapies, 2022-2035 (USD Billion)
Figure 14.5 Lyophilization Services Market for Vaccines, 2022-2035 (USD Billion)
Figure 14.6 Lyophilization Services Market for Other Biologics, 2022-2035 (USD Billion)
Figure 14.7 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, 2022 and 2035 (USD Billion)
Figure 14.8 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, 2022-2035 (USD Billion)
Figure 14.9 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, 2022- 2035 (USD Billion)
Figure 14.10 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, 2022-2035 (USD Billion)
Figure 14.11 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, 2022-2035 (USD Billion)
Figure 14.12 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, 2022-2035 (USD Billion)
Figure 14.13 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, 2022 and 2035 (USD Billion)
Figure 14.14 Lyophilization Services Market for Biopharmaceuticals in North America, 2022- 2035 (USD Billion)
Figure 14.15 Lyophilization Services Market for Biopharmaceuticals in Europe, 2022- 2035 (USD Billion)
Figure 14.16 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, 2022- 2035 (USD Billion)
Figure 14.17 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, 2022- 2035 (USD Billion)
Figure 14.18 Lyophilization Services Market for Biopharmaceuticals in Latin America, 2022- 2035 (USD Billion)
Figure 14.19 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, 2022- 2035 (USD Billion)
Figure 15.1 Concluding Remarks: Overall Market Landscape
Figure 15.2 Concluding Remarks: Benchmark Analysis
Figure 15.3 Concluding Remarks: Partnership and Collaborations
Figure 15.4 Concluding Remarks: Recent Expansions
Figure 15.5 Concluding Remarks: Market Forecast
List Of Tables
Table 4.1 List of Lyophilization Service Providers for Biopharmaceuticals
Table 5.1 Benchmark Analysis: Information on Peer Groups
Table 6.1 Leading Lyophilization Service Providers for Biopharmaceuticals in North America
Table 6.2 Baxter BioPharma Solutions: Company Snapshot
Table 6.3 Baxter BioPharma Solutions: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.4 Baxter BioPharma Solutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.5 Baxter BioPharma Solutions: Recent Developments and Future Outlook
Table 6.6 Curia: Company Snapshot
Table 6.7 Curia: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.8 Curia: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.9 Curia: Recent Developments and Future Outlook
Table 6.10 Emergent BioSolutions: Company Snapshot
Table 6.11 Emergent BioSolutions: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.12 Emergent BioSolutions: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.13 Emergent BioSolutions: Recent Developments and Future Outlook
Table 6.14 LSNE Contract Manufacturing: Company Snapshot
Table 6.15 LSNE Contract Manufacturing: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.16 LSNE Contract Manufacturing: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.17 LSNE Contract Manufacturing: Recent Developments and Future Outlook
Table 6.18 Lyophilization Technology: Company Snapshot
Table 6.19 Lyophilization Technology: Lyophilization Service Offerings for Biopharmaceuticals
Table 6.20 Lyophilization Technology: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 6.21 Lyophilization Technology: Recent Developments and Future Outlook
Table 7.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Europe
Table 7.2 CordenPharma: Company Snapshot
Table 7.3 CordenPharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.4 CordenPharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.5 CordenPharma: Recent Developments and Future Outlook
Table 7.6 Coriolis Pharma: Company Snapshot
Table 7.7 Coriolis Pharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.8 Coriolis Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.9 Coriolis Pharma: Recent Developments and Future Outlook
Table 7.10 Northway Biotech: Company Snapshot
Table 7.11 Northway Biotech: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.12 Northway Biotech: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.13 Northway Biotech: Recent Developments and Future Outlook
Table 7.14 ProJect Pharmaceutics: Company Snapshot
Table 7.15 ProJect Pharmaceutics: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.16 ProJect Pharmaceutics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.17 Vetter Pharma: Company Snapshot
Table 7.18 Vetter Pharma: Lyophilization Service Offerings for Biopharmaceuticals
Table 7.19 Vetter Pharma: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 7.20 Vetter Pharma: Recent Developments and Future Outlook
Table 8.1 Leading Lyophilization Service Providers for Biopharmaceuticals in Asia Pacific
Table 8.2 BioZed Engineering: Company Snapshot
Table 8.3 BioZed Engineering: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.4 BioZed Engineering: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.5 BioZed Engineering: Recent Developments and Future Outlook
Table 8.6 CinnaGen: Company Snapshot
Table 8.7 CinnaGen: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.8 CinnaGen: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.9 CinnaGen: Recent Developments and Future Outlook
Table 8.9 MabPlex: Company Snapshot
Table 8.10 MabPlex: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.11 MabPlex: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.12 MabPlex: Recent Developments and Future Outlook
Table 8.13 Samsung Biologics: Company Snapshot
Table 8.14 Samsung Biologics: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.15 Samsung Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.16 Samsung Biologics: Recent Developments and Future Outlook
Table 8.17 WuXi Biologics: Company Snapshot
Table 8.18 WuXi Biologics: Lyophilization Service Offerings for Biopharmaceuticals
Table 8.19 WuXi Biologics: Information on Dedicated Biopharmaceutical Lyophilization Facilities
Table 8.20 WuXi Biologics: Recent Developments and Future Outlook
Table 9.1 Lyophilization Services for Biopharmaceuticals: List of Partnerships and Collaborations, 2018-2021
Table 10.1 Lyophilization Services for Biopharmaceuticals: List of Recent Expansions, 2018-2021
Table 11.1 Lyophilization Services Market for Biopharmaceuticals: List of Respondents
Table 12.1 Lyophilization Cycle Development and Optimization: List of Service Providers
Table 12.2 BSP Pharmaceuticals: Company Snapshot
Table 12.3 CuriRx: Company Snapshot
Table 12.4 GILYOS: Company Snapshot
Table 12.5 Pierre Fabre: Company Snapshot
Table 12.6 Singota Solutions: Company Snapshot
Table 13.1 Spray Drying for Biopharmaceuticals: List of Service Providers
Table 13.2 Comparison of Lyophilization and Spray Drying Process
Table 16.1 Pharmaceutical International: Company Snapshot
Table 16.2 Curia: Company Snapshot
Table 16.3 Emergent BioSolutions: Company Snapshot
Table 16.4 Liof Pharma: Company Snapshot
Table 16.5 Vibalogics: Company Snapshot
Table 16.6 Samsung Biologics: Company Snapshot
Table 16.7 Bioserv: Company Snapshot
Table 16.8 Symbiosis Pharmaceutical Services: Company Snapshot
Table 16.9 Patheon: Company Snapshot
Table 16.10 Baxter BioPharma Solutions: Company Snapshot
Table 17.1 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Year of Establishment
Table 17.2 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Company Size
Table 17.3 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Location of Headquarters
Table 17.4 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Scale of Operation
Table 17.5 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Regulatory Certification / Accreditation
Table 17.6 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized
Table 17.7 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Process of Lyophilization
Table 17.8 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Type of Primary Packaging System
Table 17.9 Lyophilization Service Providers for Biopharmaceuticals: Distribution by Additional Services Offered
Table 17.10 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VII
Table 17.11 Benchmark Analysis: Asia Pacific and Rest of the World, Peer Group VIII
Table 17.12 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Table 17.13 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.14 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 17.15 Most Active Players: Distribution by Number of Partnerships
Table 17.16 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Table 17.17 Partnerships and Collaborations: International and Local Deals
Table 17.18 Recent Expansions: Cumulative Year-wise Trend, 2018-2021
Table 17.19 Recent Expansions: Distribution by Type of Expansion
Table 17.20 Recent Expansions: Distribution by Year and Type of Expansion
Table 17.21 Recent Expansions: Distribution by Company Size and Location of Headquarters
Table 17.22 Recent Expansions: Distribution by Location of Expanded Facility
Table 17.23 Recent Expansions: Distribution by Location of Expanded Facility and Type of Expansion
Table 17.24 Active Players: Distribution by Number of Recent Expansions
Table 17.25 Recent Expansions: Distribution by Geography
Table 17.26 Survey Analysis: Distribution by Geographical Location of Respondents
Table 17.27 Survey Analysis: Distribution by Seniority Levels of Respondents
Table 17.28 Survey Analysis: Distribution by Type of Biologic Lyophilized
Table 17.29 Survey Analysis: Distribution by Type of Primary Packaging System
Table 17.30 Survey Analysis: Distribution by Scale of Operation
Table 17.31 Survey Analysis: Distribution by Additional Services Offered
Table 17.32 Survey Analysis: Distribution by Location of Lyophilization Facility
Table 17.33 Survey Analysis: Distribution by Share of Lyophilization Operations Outsourced
Table 17.34 Survey Analysis: Distribution by Likely Current Market Size
Table 17.35 Survey Analysis: Distribution of Likely Market Share by Type of Biologic Lyophilized
Table 17.36 Survey Analysis: Distribution Likely Market Share by Geography
Table 17.37 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Company Size
Table 17.38 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Location of Headquarters
Table 17.39 Lyophilization Cycle Development and Optimization Service Providers: Distribution by Type of Service Offered
Table 17.40 Global Lyophilization Services Market for Biopharmaceuticals, 2022-2035 (USD Billion)
Table 17.41 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Biologic Lyophilized, 2022 and 2035 (USD Billion)
Table 17.42 Lyophilization Services Market for Antibodies, 2022-2035 (USD Billion)
Table 17.43 Lyophilization Services Market for Cell and Gene Therapies, 2022-2035 (USD Billion)
Table 17.44 Lyophilization Services Market for Vaccines, 2022-2035 (USD Billion)
Table 17.45 Lyophilization Services Market for Other Biologics, 2022-2035 (USD Billion)
Table 17.46 Lyophilization Services Market for Biopharmaceuticals: Distribution by Type of Primary Packaging System, 2022 and 2035 (USD Billion)
Table 17.47 Lyophilization Services Market for Biopharmaceuticals Stored in Vials, 2022-2035 (USD Billion)
Table 17.48 Lyophilization Services Market for Biopharmaceuticals Stored in Syringes, 2022- 2035 (USD Billion)
Table 17.49 Lyophilization Services Market for Biopharmaceuticals Stored in Cartridges, 2022- 2035 (USD Billion)
Table 17.50 Lyophilization Services Market for Biopharmaceuticals Stored in Ampoules, 2022- 2035 (USD Billion)
Table 17.51 Lyophilization Services Market for Biopharmaceuticals Stored in Other Primary Packaging Systems, 2022- 2035 (USD Billion)
Table 17.52 Lyophilization Services Market for Biopharmaceuticals: Distribution by Geography, 2022 and 2035 (USD Billion)
Table 17.53 Lyophilization Services Market for Biopharmaceuticals in North America, 2022- 2035 (USD Billion)
Table 17.54 Lyophilization Services Market for Biopharmaceuticals in Europe, 2022- 2035 (USD Billion)
Table 17.55 Lyophilization Services Market for Biopharmaceuticals in Asia Pacific, 2022- 2035 (USD Billion)
Table 17.56 Lyophilization Services Market for Biopharmaceuticals in Middle East and North Africa, 2022- 2035 (USD Billion)
Table 17.57 Lyophilization Services Market for Biopharmaceuticals in Latin America, 2022- 2035 (USD Billion)
Table 17.58 Lyophilization Services Market for Biopharmaceuticals in Rest of the World, 2022- 2035 (USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie
  • Affinity Biologicals (Acquired by Precision BioLogic)
  • Affinity Life Sciences
  • Air Products
  • Ajinomoto Bio-Pharma Services
  • Alcami
  • APTSol 
  • Arbor Investments
  • Argonaut Manufacturing Services
  • Attwill Medical Solutions
  • Axcellerate Pharma (Acquired by Generic Specialties)
  • Baccinex
  • Basic Pharma
  • Baxter BioPharma Solutions
  • Berkshire Sterile Manufacturing
  • BioConnection
  • Biofortuna
  • BIOLYPH
  • Biopharma Group
  • BioReliance
  • Bioserv 
  • BioTechLogic
  • BioTechnique
  • BioZed Engineering
  • Boehringer Ingelheim
  • Bovogen Biologicals
  • Bryllan
  • BSP Pharmaceuticals
  • Burrard Pharmaceuticals
  • Canada Peptide
  • CARBOGEN AMCIS (Acquired by Dishman Pharmaceuticals and Chemicals)
  • Catalent
  • Cenexi 
  • CinnaGen
  • CoolVacuum (Acquired by Dara Pharma)
  • CordenPharma
  • Coriolis Pharma
  • Curia
  • CuriRx
  • Dalton Pharma Services (Acquired by Seikagaku)
  • Dara Pharmaceutical Equipment
  • DavosPharma
  • Emergent BioSolutions
  • EnWave
  • Eurofins
  • Eurogentec
  • Eurolyo (A Subsidiary of Groupe)
  • European Medical Contract Manufacturing (EMCM)
  • FAMAR
  • Flow Sciences
  • Fluorogenics (Acquired by New England Biolabs)
  • Fresenius Kabi 
  • GEA
  • GeneMe
  • GILYOS
  • Gipharma (Acquired by Advanced Accelerator Applications)
  • GlaxoSmithKline (GSK)
  • Goodwin Biotechnology
  • GP Pharm
  • Grand River Aseptic Manufacturing (GRAM)
  • Groupe Berkem
  • HALIX
  • HTD Biosystems
  • Hycult Biotech
  • IBEX Pharmaceuticals 
  • IDT Biologika
  • Integrated DNA Technologies (IDT)
  • Integrity Bio (Acquired by Curia)
  • IRISYS (Acquired by Societal CDMO)
  • Jubilant HollisterStier
  • KABS Pharmaceutical Services
  • Kemp Proteins
  • Kemwell Biopharma
  • Lab-i-DOSiTECNO Pharma Technologies
  • Labyrinth BioPharma (Formerly known as AB BioTechnologies)
  • LakePharma (Acquired by Curia)
  • Liof Pharma
  • Lonza
  • LSNE Contract Manufacturing (Acquired by PCI Pharma Services)
  • Luina Bio
  • LYOCONTRACT 
  • LyoGen (Acquired by Argonaut Manufacturing Services)
  • LyoHUB
  • Lyophilization Technology (LTI)
  • MabPlex
  • MBU-Technology
  • Medicago
  • Miltenyi Biotec
  • Mycenax Biotech
  • nanoTools Antibody Technology
  • National Collection of Industrial, Food and Marine Bacteria (NCIMB)
  • Nektar Therapeutics 
  • New England Biolabs (NEB)
  • Nitto Avecia Pharma Services
  • Northway Biotech
  • Oncotec Pharma Produktion
  • OPTIMA pharma 
  • Oregon Freeze Dry (Acquired by Arbor Investments)
  • Parker Freeze Dry
  • Patheon (Acquired by Thermo Fischer Scientific)
  • PaxVax
  • PCI Pharma Services
  • Pfizer CentreOne
  • Pharma Gen
  • Pharmaceutics International
  • Pierre Fabre
  • Piramal Pharma Solutions
  • Precision BioLogic 
  • Premas Biotech
  • Profacgen
  • ProForm Fabrication
  • ProJect Pharmaceutics
  • PSC Biotech
  • PYRAMID Laboratories
  • Quality BioResources
  • Recipharm
  • Rentschler Fill Solutions
  • Resilience
  • SafeBridge Consultants
  • Samsung Biologics
  • Seikagaku
  • Sentinel Diagnostics
  • Singota Solutions
  • SP Scientific
  • Sublime Stericeuticals
  • Symbiosis Pharmaceutical Services
  • SynCo Bio Partners
  • SYNERLAB Group
  • Therapure Biopharma (Acquired by Resilience)
  • TriPharm Services (Acquired by Alcami)
  • Vetter Pharma
  • Vibalogics
  • VxP Pharma
  • Wacker Biotech
  • WuXi Biologics

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Microbiome Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size, Key Geographical Regions and Leading Developers - Product Image

Microbiome Manufacturing Market (3rd Edition): Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size, Key Geographical Regions and Leading Developers

  • Report
  • 286 Pages
  • Global
From
Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size and Key Geographical Regions - Product Image

Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size and Key Geographical Regions

  • Report
  • 799 Pages
  • Global
From
Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, Service (Process Development), Drug Type (Biologics, Biosimilars), Type, Scale of Operation, Therapeutic Area, Region, and Segment Forecasts, 2025-2030 - Product Image

Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, Service (Process Development), Drug Type (Biologics, Biosimilars), Type, Scale of Operation, Therapeutic Area, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Forecast to 2029 - Product Image

Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Forecast to 2029

  • Report
  • 248 Pages
  • Global
From
Biologics CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Biologics CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.